Finance

Lists
Outlook: 95.2% bullish·0.0% bearish
Go to analysis
CI:NYSE
Cigna Group
$274.37
+1.14%
(+3.08) 1D
$274.37
0.00% (0.00)
After hours
Closed: Oct 6, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CI...
Open
$271.72
High
$275.82
Low
$270.00
Mkt. cap
72.30B
Avg. vol.
1.61M
Volume
1.09M
Dividend
2.27%
Quarterly dividend
$1.56
Ex-dividend date
Sep 8, 2026
P/E ratio
11.37
52-wk high
$312.18
52-wk low
$239.51
EPS
$24.13
Beta
0.29
Shares outstanding
264.24M
No. of employees
67K
Open
$271.72
High
$275.82
Low
$270.00
Mkt. cap
72.30B
Avg. vol.
1.61M
Volume
1.09M
Dividend
2.27%
Quarterly dividend
$1.56
Ex-dividend date
Sep 8, 2026
P/E ratio
11.37
52-wk high
$312.18
52-wk low
$239.51
EPS
$24.13
Beta
0.29
Shares outstanding
264.24M
No. of employees
67K
News stories
From web sources and news partners
Profile
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups. Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them. Wikipedia
About Cigna Group
CEO-
Employees66.7K
Founded1792
HeadquartersBloomfield, Connecticut, United States
SectorHealth care provider
Website-
Analyst ratings
Based on 19 analysts giving stock ratings to CI in the past 3 months
Buy
Buy
13
Hold
6
Sell
0
12-month forecast
Based on 19 Wall Street analysts offering 12 month price targets for CI in the last 3 months.
Highest
Current $274.37
$387.00 (+41.05%)
Average
$338.89 (+23.52%)
Lowest
$290.00 (+5.70%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lance Wilkes
Bernstein
Buy
Maintained
$387.00
+41.1%
10/05/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$350.00
+27.6%
10/02/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
$370.00
+34.9%
10/02/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$290.00
+5.7%
10/01/2026
Unknown Analyst
Leerink Partners
Hold
Reiterated
$300.00
+9.3%
10/01/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$365.00
+33%
10/01/2026
Charles Rhyee
TD Cowen
Buy
Maintained
$338.00
+23.2%
09/30/2026
Ben Hendrix
RBC Capital
Buy
Maintained
$337.00
+22.8%
09/30/2026
Stephen Baxter
Wells Fargo
Hold
Maintained
$307.00
+11.9%
09/30/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
$378.00
+37.8%
10/01/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$310.00
+13%
10/01/2026
Erin Wright
Morgan Stanley
Buy
Maintained
$361.00
+31.6%
09/29/2026
David Windley
Jefferies
Hold
Downgraded
$307.00
+11.9%
08/03/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
$352.00
+28.3%
08/02/2026
Parker Snure
Raymond James
Buy
Maintained
$320.00
+16.6%
08/03/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
07/30/2026
George Hill
Deutsche Bank
Hold
Maintained
$305.00
+11.2%
07/31/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$365.00
+33%
07/31/2026
Jailendra Singh
Truist Financial
Buy
Reiterated
$350.00
+27.6%
07/31/2026
Michael Ha
Robert W. Baird
Buy
Maintained
$362.00
+31.9%
07/31/2026
Jason Cassorla
Guggenheim
Buy
Maintained
$361.00
+31.6%
07/30/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$340.00
+23.9%
06/08/2026
A.J. Rice
UBS
Buy
Maintained
$400.00
+45.8%
05/22/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Reiterated
$340.00
+23.9%
04/30/2026
Sarah James
Cantor Fitzgerald
Buy
Reiterated
$340.00
+23.9%
04/30/2026
Joanna Gajuk
Bank of America Securities
Buy
Maintained
$378.00
+37.8%
04/13/2026
Kevin Caliendo
UBS
Buy
Maintained
$375.00
+36.7%
02/09/2026
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$7.78 / $7.60
+2.37%beat
Revenue / Est. (USD)
71.67B / 70.18B
+2.12%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
69.75B
72.47B
68.49B
71.67B
Cost of goods sold
63.37B
66.06B
62.02B
65.13B
Cost of revenue
63.37B
66.06B
62.02B
65.13B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.15B
3.40B
2.33B
3.29B
Operating expense
3.59B
3.86B
2.72B
3.68B
Total operating expenses
66.96B
69.91B
64.74B
68.81B
Operating income
2.79B
2.56B
3.75B
2.86B
Other non operating income
16.00M
-62.00M
-357.00M
3.00M
EBT including unusual items
2.30B
1.82B
2.27B
2.26B
EBT excluding unusual items
2.44B
2.20B
3.40B
2.50B
Income tax expense
322.00M
543.00M
409.00M
382.00M
Effective tax rate
14.03%
29.88%
18.02%
16.93%
Other operating expenses
-
-
-
-
Net income
1.87B
1.23B
1.65B
1.66B
Net profit margin
2.68%
1.70%
2.41%
2.32%
Earnings per share
7.83
8.08
7.79
7.78
Interest and investment income
-
-
-
-
Interest expense
-363.00M
-300.00M
-
-359.00M
Net interest expenses
-363.00M
-300.00M
-
-359.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.49B
3.28B
4.40B
3.51B
Gain or loss from assets sale
-38.00M
66.00M
-11.00M
-6.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps